Contact: Vanessa Pavinato
European Society for Medical Oncology
Caption: Heterogeneity of breast cancer; multigene signatures to determine prognosis; biopsying metastases; emerging pathways; new imaging techniques... This and much more awaits you at IMPAKT if you want a full vision of breast cancer biology and be able to use it to better treat patients. Andrew Tutt and Peter Dubsky, IMPAKT 2013 co-chairs, anticipate some of the most appealing topics the will form the high-level program of the conference that aims to improve outcome in breast cancer through translational research.
Credit: European Society for Medical Oncology ©
Usage Restrictions: None